Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study

Scully, M; de la Rubia, J; Pavenski, K; Metjian, A; Knobl, P; Peyvandi, F; Cataland, S; Coppo, P; Hovinga, JAK; Edou, JMM; Sousa, RD; Callewaert, F; Gunawardena, S; Lin, J

Scully, M (通讯作者)，Univ Coll London Hosp, 250 Euston Rd, London NW1 2PG, England.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (12): 2810

Abstract

Introduction Caplacizumab demonstrated efficacy and safety in patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in the phase 3 ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索